News

August 2, 2011 — St. Jude Medical Inc. today announced the first patient was enrolled in the EAST (Early comprehensive Atrial fibrillation Stroke prevention Trial) clinical trial.

Home August 02, 2011
Home
News

Aug. 2, 2011 — New York University (NYU) Langone Medical Center has received an $84 million grant from the National Heart, Lung and Blood Institute (NHLBI) to study the comparative effectiveness of two management strategies for patients with coronary artery disease (CAD). NHLBI is part of the National Institutes of Health (NIH).

Home August 02, 2011
Home
News

August 2, 2011 – The American Society of Echocardiography (ASE) has developed iASE, a tool that provides clear, concise summaries of the ASE’s most popular guidelines as applications for mobile devices. This highly portable tool allows physicians to access guidelines and calculators for echocardiography in one place, combining many steps traditionally taken by practitioners into one easy step, according to Chi-Ming Chow, M.D., associate professor of medicine at the University of Toronto and staff cardiologist at St. Michael’s Hospital, Toronto, Ontario. Chow, part of the team that created the application for ASE’s Information Technology (IT) Committee, noted that while ASE’s posters and pocket guides to the guidelines for cardiovascular ultrasound are wonderful in traditional settings, the mobile application can be used by practitioners anywhere: at the patient’s bedside, while teaching residents how to take measurements or when sharing calculations with sonographers, making it an ideal teaching and reference tool.

Home August 02, 2011
Home
News

August 2, 2011 – WorldHeart, which is developing ventricular assist devices designed for adults, children and infants suffering from heart failure, announced that it will cease its efforts to commercialize the Levacor ventricular assist device (VAD) technology and will focus its resources on developing and commercializing its smaller, next-generation MiFlow VAD.

Home August 02, 2011
Home
News

August 2, 2011 – An estimated 1.7 million clinical positron emission tomography (PET) patient studies were performed in the United States in 2010, according to a report just released by IMV Medical Information Division. These PET studies were performed in 2,085 hospital and non-hospital sites, using fixed or mobile PET/computed tomography (CT) or PET scanners.

Home August 02, 2011
Home
Videos | Resuscitation Devices

Paramedics in Bellingham, Wash., used the Lucas device on patient Nancy Olson, who went into cardiac arrest following a ...

Home August 01, 2011
Home
News

July 29, 2011 – Philips installed a MultiDiagnost Eleva X-ray system at Delray Medical Center, a 493-bed acute care hospital serving southeast Florida, and MultiDiagnost Eleva with 3-D-RX reconstruction technology at West Boca Medical Center, an award-winning facility serving Boca Raton and Palm Beach county regions. The hospitals are part of Tenet Healthcare Corporation, one of the largest investor-owned healthcare delivery systems in the nation.

Home July 29, 2011
Home
News

July 29, 2011 — InspireMD Inc., developer of the MGuard mesh protective stent system, announced that the first patient has been enrolled in the MASTER (MGuard for Acute ST Elevation Reperfusion) randomized trial. It is a multinational, randomized, controlled trial designed to demonstrate MGuard coronary stent's superiority over standard care for heart attack patients.

Home July 29, 2011
Home
News

July 29, 2011 — Oxygen Biotherapeutics Inc. and privately held Aurum Biosciences Ltd. of Glasgow, Scotland, have signed a letter of intent (LOI) to conduct preclinical research for imaging and therapeutic intervention of acute ischemic stroke. Aurum, using Oxygen’s proprietary Oxycyte PFC (perfluorocarbon) emulsion in combination with Aurum’s proprietary Glasgow Oxygen Level Dependent (GOLD) magnetic resonance imaging (MRI) techniques, will conduct the research.

Home July 29, 2011
Home
News

July 29, 2011 — Boston Scientific Corporation's board of directors has approved a five-year, $150 million investment to expand its commercial presence in China, one of the world's largest and fastest-growing medical device markets.

Home July 29, 2011
Home
News

July 29, 2011 — The U.S. Food and Drug Administration (FDA) this week issued draft guidance that clarifies when changes or modifications to a previously cleared 510(k) device require a new premarket submission.

Home July 29, 2011
Home
News

July 27, 2011 – Micell Technologies Inc. announced that it has completed patient enrollment in its DESSOLVE II CE mark clinical study of the MiStent drug-eluting coronary stent system. The MiStent DES is an ultra-thin drug-eluting stent distinguished by a rapid-absorbing drug/polymer coating formulation. Enrollment of 183 patients across 26 study centers throughout Europe and New Zealand was accomplished ahead of schedule.

Home July 27, 2011
Home
News

July 27, 2011 – A special panel convened July 21 in Gaithersburg, Md., to review the results of the Excor pediatric ventricular assist device (VAD) investigational device exemption (IDE) clinical trial. The panel convened at the request of Bram Zuckerman, M.D., director, division of cardiovascular devices, Center for Devices and Radiologic Health of the U.S. Food and Drug Administration (FDA).

Home July 27, 2011
Home
News

July 27, 2011 – A new echocardiography remote reading program was introduced to provide expert exam interpretation in all 50 states. The new program, created by USARAD.com, a Joint Commission accredited provider of imaging services, is intended to address the longstanding need for fast, reliable interpretation of echocardiograms for mobile ultrasound companies and other imaging facilities across the nation.

Home July 27, 2011
Home
News

July 27, 2011 – As the number of interventional procedures to diagnose and treat patients increases worldwide, and the procedures grow in complexity and length, exposure to radiation is a growing concern for both clinicians and patients. Interventional fluoroscopy is the third largest source of radiation from medical procedures, accounting for about 7 percent of the total radiation exposure of Americans in a year, according to a study by the National Council on Radiation Protection. GE’s Innova imaging systems help clinicians reduce radiation exposure without compromising the image quality they need to make confident decisions during interventional procedures.

Home July 27, 2011
Home
Subscribe Now